ФАРМАКОТЕРАПИЯ БИПОЛЯРНОГО АФФЕКТИВНОГО РАССТРОЙСТВА


Цитировать

Полный текст

Аннотация

Рассматриваются современные подходы к медикаментозной терапии биполярного аффективного расстройства (БАР). Представлены основные группы препаратов, применяемых для лечения БАР, их достоинства и недостатки. К их числу относятся соли лития, противосудорожные препараты, антипсихотики и антидепрессанты. Обсуждается место представителей различных фармакологических групп в лечении различных вариантов БАР.

Полный текст

Доступ закрыт

Об авторах

А. В Ушкалова

РУДН

Кафедра психиатрии и медицинской психологии Москва

Список литературы

  1. Hirschfeld R.M, Baker J.D, Wozniak P, et al. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 2003;64(7):841-46.
  2. Angst J. The emerging epidemiology of hypo -mania and bipolar II disorder. J Affective Disorders 1998;50:143-51.
  3. Glick I.D, Suppes T, DeBattista С, et al. Psychopharmacologic Treatment Strategies for Depression,Bipolar Disorder, and Schi zophrenia. Ann Intern Med 2001;134:47-60.
  4. Post R.M. The impact of bipolar depression. J Clin Psychiatry 2005;66(Suppl. 5):5-10.
  5. Fountoulakis K.N, Vieta E, Siamouli M, et al. Treatment of bipolar disorder: a complex tre atment for a multi-faceted disorder. Ann Gen Psychiatry 2007;6:27.
  6. Ahrens B, Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 2001;34:132-36.
  7. Geddes J.R, Burgess S, Hawton K, et al. Long -term lithium therapy for bipolar disorder: systematic review and meta analysis of ran domized controlled trials. Am J Psychiatry 2004;161(2): 217-22.
  8. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all cause mortality in patients with mood disor ders: a systematic review of randomized trials. Am J Psychiatry 2005;162(10):1805-19.
  9. Grunze H, Kasper S, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biolo gical treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychia try 2004;5(3):120-35.
  10. Post R.M, Leverich G.S, Altshuler L, et al. Lithium discontinuation induced refractoriness: Preliminary observations. Am J Psychia try 1992; 149:1727.
  11. Davis L.L, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a placebo controlled study. J Affect Disord 2005;85(3): 259-66.
  12. Calabrese J.R, Rapport D.J, Youngstrom E.A, et al. New data on the use of lithium, divalpro ate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry 2005;20(2):92-95.
  13. Vieta E. Managing Bipolar Disorder in Clinical Practice. Published by Current medicine group Ltd, Porters South, London, UK, 2006.
  14. Bowden C.L, Brugger A.M, Swann A.C, et al. Efficacy of divalproex sodium versus lithium and placebo in the treatment of acute mania. JAMA 1994;271:918-24.
  15. Keck P.E, McElroy S.L, Tugrul K.C, et al. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-08.
  16. Goodwin G.M. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.Br J Psychiatry 1994;164(2):149-52.
  17. Davis L.L, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a place bo-controlled study. J Affect Disord 2005;85 (3): 259-66.
  18. Gyulai L, Bowden CL, McElroy S.L, et al. Main tenance efficacy of divalproex in the preven tion of bipolar depression. Neuropsychophar macology 2003;28(7):1374-82.
  19. Bowden C.L, Calabrese J.R, McElroy S.L, et al. Efficacy of divalproex versus lithium and pla cebo in the maintenance treatment of bipolar disorder. Arch Gen Psychiatry 2000;57:481-89.
  20. 0wen R.T. Extended-release carbamazepine for acute bipolar mania: a review. Drugs Today (Barc) 2006;42(5):283-89.
  21. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(Suppl. 1):2-10.
  22. El-Mallakh R.S, Ketter T.A, Weisler R.H, et al. Switching from other agents to exten ded release carbamazepine in acute mania. Psychopharmacol Bull 2008;41:52-58.
  23. Calabrese J.R, Bowden C.L, Sachs G, et al. A placebocontrolled 18-month trial of lamotrigine and lithium maintenance treatment in recent ly depressed patients with bipolar I disorder.J Clin Psychiatry 2003;64(9):1013-24.
  24. Bowden C.L, Calabrese J.R, Sachs G, et al. A placebo -controlled 18-month trial of lamotrigine and lithium maintenance treatment in recent ly manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60(4):392-400.
  25. Calabrese J.R, Goldberg J.F, Ketter T.A, et al. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double blind maintenance studies. Biol Psychiatry 2006;59(11): 1061-64.
  26. Landmark J.C. Antiepileptic drugs in non epile psy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008;22(1):27-47.
  27. Janicak P.G, Newman R.H, Davis J.M. Advances in the treatment of mania and related disor ders: a reappraisal. Psychiatr Ann 1992;22:92-103.
  28. Strawn J.R, Delbello M.P. Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin Pharmacother 2008; 9:467-74.
  29. Girgis R.R, Javitch J.A, Lieberman J.A. Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway. Mol Psychiatry. 2008 April 15 [Epub ahead of print].
  30. Sachs G, Chengappa K.N, Suppes T, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6(3):213-23.
  31. Bowden C.L, Grunze H, Mullen J, et al. A randomized, double blind, placebo control led efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66(1):111-21.
  32. Thase M.E, Macfadden W, Weisler R.H, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebocontrolled study (the BOLDER II study). J Clin Psychopharmacol 2006;26(6):600-09.
  33. Cookson J, Keck P.E, Ketter T.A, et al. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo controlled study. Int Clin Psychopharmacol 2007;22(2):93-100.
  34. Endicott J, Rajagopalan K, Minkwitz M, et al. A randomized, double blind, placebo con trolled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 2007;22(1):29-37.
  35. Vieta E, Parramon G, Padrell E, et al. Quetiapine in the treatment of rapid cycling bipolar disorder.Bipolar Disord 2002;4:335-40.
  36. Keck P.E, Marcus R, Tourkodimitris S, et al. A placebo controlled, double blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003; 160(9):1651-58.
  37. Sachs G, Sanchez R, Marcus R, et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 2006;20(4):536-46.
  38. Potkin S.G, Keck P.E, Segal S, et al. Ziprasidone in acute bipolar mania: a 21 day randomized, double blind, placebo controlled replication trial. J Clin Psychopharmacol 2005;25(4):301-10.
  39. Keck P.E, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three week, placebo controlled, double blind, randomized trial. Am J Psychiatry 2003;160 (4): 741-48.
  40. Malhi G.S, Mitchell P.B, Salim S. Bipolar depres sion: management options. CNS Drugs 2003;17(1):9-25.
  41. Gijsman H.J, Geddes J.R, Rendell J.M, et al. Anti depressants for bipolar depression: a systema tic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-47.
  42. Fountoulakis K.N, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 2005;86(1):1-10
  43. Sachs G.S, Nierenberg A.A, Calabrese J.R, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. N Engl J Med 2007;356:1711-22.
  44. Vieta E, Martinez-Aran A, Goikolea J.M, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002;63(6):508-12.
  45. Leverich G.S, Altshuler L.L, Frye M.A, et al. Risk of switching in mood polarity to hypomania and mania in patients with bipolar depres sion during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163:232-39.
  46. Post R.M, Altshuler L.L, Frye M.A, et al. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Curr Psychiatry Rep 2006;8(6):489-97.
  47. Frances A.J, Docherty J.P, Kahn D.A. The Expert Consensus Guideline Series: Treatment of Bipo lar Disorder. J Clin Psychiatry 1996;57(Suppl. 12a):1-88.
  48. Wittington C, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-45.
  49. Bauer M.S, Wisniewski S.R, Marangell L.B, et al. Are antidepressants associated with new onset suicidality in bipolar disorder? A prospective study of participants in the Syste matic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2006;67(1):48-55.
  50. National Institute for Health and Clinical Excel lence Bipolar disorder.The management of bipolar disorder in adults, children and ado lescents, in primary and secondary care. July 2006 http://www.nice.org.uk/nicemedia/pdf/ CG38niceguideline.pdf.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2008

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах